Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Celcuity Inc. - Common Stock (NQ:CELC)

140.60 +0.26 (+0.19%)
Streaming Delayed Price Updated: 12:52 PM EDT, May 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 281,150
Open 137.45
Bid (Size) 140.30 (200)
Ask (Size) 140.91 (100)
Prev. Close 140.34
Today's Range 135.24 - 140.83
52wk Range 10.26 - 151.02
Shares Outstanding 46,271,259
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗
Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗
This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through late-stage trials. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+39.8%
+39.8%
1 Month
+17.1%
+17.1%
3 Month
+33.0%
+33.0%
6 Month
+49.2%
+49.2%
1 Year
+1220.2%
+1220.2%

More News

Read More
News headline image
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗
Via The Motley Fool
Celcuity Inc. (NASDAQ:CELC) Q1 Earnings Beat Forecasts, But Stock Drops on Phase 3 Data Focus ↗
Via Chartmill
Topics Earnings
Celcuity Inc. (NASDAQ:CELC) Reports Q4 Earnings Beat and Key FDA Priority Review for Gedatolisib ↗
Via Chartmill
Topics Earnings
News headline image
Celcuity Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Celcuity (CELC) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗
Via The Motley Fool
Traders are paying attention to the gapping stocks in Monday's session. ↗
Via Chartmill
Discover the top movers in Monday's pre-market session. ↗
Via Chartmill
News headline image
Why Celcuity Stock Popped on Monday ↗
Via The Motley Fool
News headline image
Why Celcuity Stock Popped Today ↗
Via The Motley Fool
News headline image
The Great Rotation: Russell 2000 Outshines Mega-Caps as Domestic Small-Caps Take the Reins in 2026
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? ↗
Via The Motley Fool
News headline image
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Apis Capital Trims Holdings of Celcuity Stock, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Manager Closes Position in GEO Stock, Sells $17.6 Million Worth of Shares, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Immigration Regulatory Compliance
News headline image
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Great Rotation of 2026: Why Small-Cap 'Underdogs' are Finally Outpacing the Tech Titans
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Apis Capital Expands Garrett Motion Stake as Hybrid Demand Extends the Combustion Cycle ↗
Via The Motley Fool
Topics Economy Emissions Regulatory Compliance
News headline image
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Celcuity Inc. - Common Stock publicly traded?
Yes, Celcuity Inc. - Common Stock is publicly traded.
What exchange does Celcuity Inc. - Common Stock trade on?
Celcuity Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Celcuity Inc. - Common Stock?
The ticker symbol for Celcuity Inc. - Common Stock is CELC on the Nasdaq Stock Market
What is the current price of Celcuity Inc. - Common Stock?
The current price of Celcuity Inc. - Common Stock is 140.60
When was Celcuity Inc. - Common Stock last traded?
The last trade of Celcuity Inc. - Common Stock was at 05/21/26 12:52 PM ET
What is the market capitalization of Celcuity Inc. - Common Stock?
The market capitalization of Celcuity Inc. - Common Stock is 6.51B
How many shares of Celcuity Inc. - Common Stock are outstanding?
Celcuity Inc. - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.